Last edition
News about Global Pharma
Astellas and YASKAWA to Establish Joint Venture Focused on Cell Therapy Manufacturing
The planned joint venture will leverage Astellas' expertise in R&D and manufacturing for cell therapy and the dual arm robot ‘Maholo’, developed by YASKAWA's subsidiary, Robotic Biology Institute.
Global Pharma | 06/03/2025 | By Aishwarya | 305
Syntegon to Showcase New Filling Solution for RTU Syringes at Interphex
A new robotic handling unit is also at the heart of Syntegon’s patented Settle Plate Changer. It automates viable monitoring during sterile product filling.
Global Pharma | 06/03/2025 | By Aishwarya | 530
Scinai Immunotherapeutics Ltd. announced that it has entered into a Standby Equity Purchase Agreement (the SEPA) with YA II PN, Ltd. (Yorkville), a fund managed by Yorkville Advisors Global, LP.
Global Pharma | 05/03/2025 | By Manvi | 243
Senores Pharmaceuticals Strengthens Global Presence with New USFDA Approvals
The acquisition includes 13 ANDAs that have already received approval from the US Food and Drug Administration (USFDA) and one ANDA that is currently pending approval.
Global Pharma | 05/03/2025 | By Aishwarya | 626
Bhimrao Jadhav Joins NATCO Pharma as Senior VP of Formulations Operations
Jadhav holds a Bachelor’s degree in Pharmacy and brings over 30 years of experience in pharmaceutical operations management.
Global Pharma | 05/03/2025 | By Aishwarya | 1075
Frontier Scientific Solutions Announces Appointment of Keith Parent as CTO
Frontier Scientific Solutions, a provider of GMP temperature-controlled storage and Free Trade Zone (FTZ) services for the life sciences industry, announced the appointment of Keith Parent as Chief Technology Officer (CTO).
Global Pharma | 04/03/2025 | By Manvi | 421
Zydus to Develop Combination Vaccine for Shigellosis and Typhoid
Zydus Lifesciences Ltd. has announced the development of the world’s first combination vaccine for shigellosis and typhoid, supported by the Gates Foundation, to address critical gaps in childhood immunization.
Global Pharma | 04/03/2025 | By Manvi | 158
Eton Pharmaceuticals Introduces Galzin Capsules for Wilson Disease
Galzin is FDA-approved for the maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent.
Global Pharma | 04/03/2025 | By Aishwarya | 362
Biotech Fluidics Launches New Flowmeter Kit to Validate Performance of HPLC Pump
The HPLC Pump Validation Kit has been designed to accept raw data generated by the Biotech Fluidics Liquid Flowmeter PC-App and it performs all necessary flow calculations automatically.
Global Pharma | 04/03/2025 | By Aishwarya | 298
Novo Holdings Invests in Series A Launch Financing for Callio Therapeutics
The oversubscribed Series A financing was led by Frazier Life Sciences, with significant participation from Novo Holdings and other life sciences investors including Jeito Capital, Omega Funds, Norwest, ClavystBio, EDBI, Platanus, Pureos Bioventures and SEEDS Capital.
Global Pharma | 04/03/2025 | By Aishwarya | 570
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy